                               SEQUENCE LISTING

<110> SANGAMO BIOSCIENCES, INC.
 
<120> METHODS AND COMPOSITIONS FOR TREATMENT OF A BETA THALESSEMIA

<130> 8328-0117.40

<140> PCT/US2015/014103
<141> 2015-02-02

<150> 61/935,219
<151> 2014-02-03

<160> 27    

<170> PatentIn version 3.5

<210> 1
<211> 51
<212> DNA
<213> Homo sapiens


<220>
<221> CDS
<222> (1)..(21)

<400> 1
gtt ggt ggt gag gcc ctg ggc aggttggtat caaggttaca agacaggttt            51
Val Gly Gly Glu Ala Leu Gly                                               
1               5                                                         


<210> 2
<211> 44
<212> DNA
<213> Homo sapiens

<400> 2
gaggccctgg gcaggttggt atcaaggtta caagacaggt ttaa                        44


<210> 3
<211> 52
<212> DNA
<213> Homo sapiens

<400> 3
ggcaaggtga acgtggatga agttggtggt gaggccctgg gcaggttggt at               52


<210> 4
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
atctgcccag ggcctcacca ccaactt                                           27


<210> 5
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
atcaaggtta caagacaggt ttaaggag                                          28


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Ala Met Gln Thr Leu Arg Val 
1               5           


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Asp Arg Ser His Leu Ala Arg 
1               5           


<210> 8
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Arg Ser Asp Asn Leu Ser Glu 
1               5           


<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Ala Ser Lys Thr Arg Lys Asn 
1               5           


<210> 10
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Arg Asn Ser Asp Arg Thr Lys 
1               5           


<210> 11
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Leu Arg His His Leu Thr Arg 
1               5           


<210> 12
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Gln Ser Gly Thr Arg Lys Thr 
1               5           


<210> 13
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Arg Ser Asp Asn Leu Ser Thr 
1               5           


<210> 14
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Asp Ser Ala Asn Arg Ile Lys 
1               5           


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Gln Ser Gly Asn Leu His Val 
1               5           


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Ala Met Gln Thr Leu Arg Val 
1               5           


<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Thr Ser Ser Asp Arg Lys Lys 
1               5           


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Val Tyr Glu Gly Leu Lys Lys 
1               5           


<210> 19
<211> 132
<212> DNA
<213> Homo sapiens

<400> 19
aagtctgccg ttactgccct gtggggcaag gtgaacgtgg atgaagttgg tggtgaggcc       60

ctgggcaggt tggtatcaag gttacaagac aggtttaagg agaccaatag aaactgggca      120

tgtggagaca ga                                                          132


<210> 20
<211> 132
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 20
aagtctgccg ttactgccct gtggggcaag gtgaacgtgg atgaagttgg tggtgaggcc       60

ctgggcagat tggtatcaag gttacaagac aggtttaagg agaccaatag aaactgggca      120

tgtggagaca ga                                                          132


<210> 21
<211> 134
<212> DNA
<213> Homo sapiens

<400> 21
aagtctgccg ttactgccct gtggggcaag gtgaacgtgg atgaagttgg tggtgaggcc       60

ctgggcaggt tggtatctag aggttacaag acaggtttaa ggagaccaat agaaactggg      120

catgtggaga caga                                                        134


<210> 22
<211> 134
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 22
aagtctgccg ttactgccct gtggggcaag gtgaacgtgg atgaagttgg tggtgaggcc       60

ctgggcagat tggtatctag aggttacaag acaggtttaa ggagaccaat agaaactggg      120

catgtggaga caga                                                        134


<210> 23
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: "LAGLIDADG" family motif peptide

<400> 23
Leu Ala Gly Leu Ile Asp Ala Asp Gly 
1               5                   


<210> 24
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 24
aatctgccca gggcctcacc accaactt                                          28


<210> 25
<211> 7
<212> PRT
<213> Homo sapiens

<400> 25
Val Gly Gly Glu Ala Leu Gly 
1               5           


<210> 26
<211> 44
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 26
gaggccctgg gcagattggt atcaaggtta caagacaggt ttaa                        44


<210> 27
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 27
gaggccctgg gcaggttggt atctagaggt tacaagacag gtttaa                      46



